Caris Life Sciences To Present Studies On Metastatic Prostate Cancer

Caris Life Sciences To Present Studies On Metastatic Prostate Cancer
Caris Life Sciences presented two studies during the 2015 Genitourinary Cancers Symposium in Orlando, Fla., highlighting the company’s comprehensive, panomic tumor profiling service, Caris Molecular Intelligence™, which can identify biomarkers to address both metastatic prostate cancer and small cell bladder cancer (SCBC). In the first study, researchers reported that Caris Molecular Intelligence detected molecular alterations associated with metastatic prostate cancer. Scientists managed to identify a

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *